The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Roche-Genentech Update

Roche raised its bid to $93 per share, more than the $89 per share it started at, and considerably more than the $86.50 per share it had been proposing lately.  No substantive response yet from Genentech’s special committee.  Keep your eyes peeled for a new SEC filing here.

Bookmark and Share

About these ads

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 126 other followers